Proteome Profiler TM Array

Transcription

1 Proteome Profiler TM Array Human Angiogenesis Array Kit Catalog Number ARY For the parallel determination of the relative levels of human angiogenesis-related proteins. This package insert must be read in its entirety before using this product. For research use only. Not for use in diagnostic procedures.

2 TABLE OF CONTENTS SECTION PAGE INTRODUCTION... PRINCIPLE OF THE ASSAY... TECHNICAL HINTS... MATERIALS PROVIDED & STORAGE CONDITIONS... PRECAUTIONS... OTHER SUPPLIES REQUIRED...3 OTHER SUPPLIES REQUIRED FOR CELL LYSATE SAMPLES...3 OTHER SUPPLIES REQUIRED FOR TISSUE LYSATE SAMPLES...3 SAMPLE COLLECTION & STORAGE... REAGENT PREPARATION... OPTIONAL PRETREATMENT... ARRAY PROCEDURE... DATA ANALYSIS... PROFILING ANGIOGENESIS-RELATED PROTEINS IN CELL CULTURE SUPERNATES...9 PROFILING ANGIOGENESIS-RELATED PROTEINS IN TUMOR TISSUE LYSATES... PROFILING ANGIOGENESIS-RELATED PROTEINS IN SERUM, PLASMA, AND SALIVA... EFFECTS OF HYPOXIA ON SOLUBLE FACTORS... APPENDIX... 3 MANUFACTURED AND DISTRIBUTED BY: USA & Canada R&D Systems, Inc. McKinley Place NE, Minneapolis, MN 3, USA TEL: () 33- () 39-9 FAX: () - info@rndsystems.com DISTRIBUTED BY: UK & Europe R&D Systems Europe, Ltd. 9 Barton Lane, Abingdon Science Park, Abingdon OX 3NB, UK TEL: + ()3 99 FAX: + () info@rndsystems.co.uk China R&D Systems China Co., Ltd. A Hua Min Empire Plaza, West Yan An Road, Shanghai PRC TEL: + () 333 FAX: + () 3 info@rndsystemschina.com.cn

3 INTRODUCTION Analyzing the expression profiles of angiogenesis-related proteins is helpful in understanding the roles these molecules play in mechanisms related to the physiological process of developing new blood vessels. The Human Angiogenesis Array kit is a rapid, sensitive, and economical tool to simultaneously detect the relative levels of expression of angiogenesis related proteins without performing individual assays for each protein. PRINCIPLE OF THE ASSAY Carefully selected capture antibodies have been spotted in duplicate on nitrocellulose membranes. Samples are diluted and mixed with a cocktail of biotinylated detection antibodies. The sample/antibody mixture is then incubated with the Human Angiogenesis Array. Any protein/detection antibody complex present is bound by its cognate immobilized capture antibody on the membrane. Following a wash to remove unbound material, Streptavidin-HRP and chemiluminescent detection reagents are added sequentially. Light is produced at each spot in proportion to the amount of analyte bound. Refer to the Appendix for a list and coordinates of analytes and controls. TECHNICAL HINTS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. This kit should not be used beyond the expiration date on the kit label. Do not mix or substitute reagents with those from other lots or sources. Substitution of some high intensity chemiluminescent reagents for Chemi Reagents and may cause either increased background or diminished signal depending on the reagent. Any variation in sample handling, buffers, operator, pipetting technique, washing technique, and incubation time or temperature can alter the performance of the kit. The Human Angiogenesis Array membranes are validated for single use only. Always use gloved hands and flat-tipped tweezers to handle the membranes. Pick up the membranes from the edge on the side with the identification number avoiding the area with the printed antibodies. A thorough and consistent wash technique is essential for proper assay performance. Individual arrays should be washed in separate containers to minimize background. Wash Buffer should be removed completely from the membrane before proceeding to the next step. Do not allow the membrane to dry out. This will cause high background. Avoid microbial contamination of reagents and buffers. Soluble receptors and other proteins present in biological samples do not necessarily interfere with the measurement of analytes in samples. Until these proteins have been tested with the Human Angiogenesis Array, the possibility of interference cannot be excluded. For a procedure demonstration video, please visit:

4 MATERIALS PROVIDED & STORAGE CONDITIONS Store the unopened kit at - C. Do not use past kit expiration date. PART PART # DESCRIPTION Human Angiogenesis Array 9333 nitrocellulose membranes each containing different capture antibodies printed in duplicate. Array Buffer 9 ml of a buffered protein base with preservatives. May contain a precipitate. Mix well be fore and during use. Array Buffer 9 ml of a buffered protein base with preservatives. Array Buffer 99 ml of a buffered protein base with preservatives. Wash Buffer Concentrate 93 vials ( ml/vial) of a -fold concentrated solution of buffered surfactant with preservative. May turn yellow over time. Detection Antibody Cocktail, Human Angiogenisis Array 933 vial of biotinylated antibody cocktail; lyophilized. Streptavidin-HRP 939 μl of streptavidin conjugated to horseradish-peroxidase. Chemi Reagent 9. ml of stabilized hydrogen peroxide with preservative. Chemi Reagent 9. ml of stabilized luminol with preservative. -Well Multi-dish Clear -well rectangular multi-dish. Transparency Overlay Template * Provided this is within the expiration date of the kit. transparency overlay template for coordinate reference. STORAGE OF OPENED/ RECONSTITUTED MATERIAL Return unused membranes to the foil pouch containing the desiccant pack. Reseal along entire edge of the zip-seal. May be stored for up to 3 months at - C.* May be stored for up to 3 months at - C.* Store at room temperature. PRECAUTIONS Chemi Reagents and contain Boric Acid which is suspected of damaging fertility or the unborn child. Do not handle until all safety precautions in the MSDS have been read and understood. Some components in this kit contain ProClin which may cause an allergic skin reaction. Avoid breathing mist. Wear protective gloves, clothing, eye, and face protection. Wash hands thoroughly after handling. Please refer to the MSDS on our website prior to use. For research use only. Not for use in diagnostic procedures.

5 OTHER SUPPLIES REQUIRED Aprotinin (Sigma, Catalog # A9) Leupeptin (Sigma, Catalog # L) Pepstatin (Sigma, Catalog # P) Igepal CA-3 (Sigma, Catalog # I3) Pipettes and pipette tips Gloves Deionized or distilled water Rocking platform shaker Microcentrifuge A plastic container with the capacity to hold ml (for washing the arrays) Plastic transparent sheet protector (trimmed to cm x cm and open on three sides) Plastic wrap Paper towels Absorbent lab wipes (KimWipes or equivalent) Autoradiography cassette Film developer X-ray film (Kodak BioMax Light-, Catalog # ) or equivalent Flat-tipped tweezers Flatbed scanner with transparency adapter capable of transmission mode Computer capable of running image analysis software and Microsoft Excel OTHER SUPPLIES REQUIRED FOR CELL LYSATE SAMPLES Phosphate-Buffered Saline (PBS) Lysis buffer (% Igepal CA-3, mm Tris-HCl (ph.), 3 mm NaCl, % glycerol, mm EDTA, μg/ml Aprotinin, μg/ml Leupeptin, and μg/ml Pepstatin) OTHER SUPPLIES REQUIRED FOR TISSUE LYSATE SAMPLES PBS with protease inhibitors ( μg/ml Aprotinin, μg/ml Leupeptin, and μg/ml Pepstatin) Triton TM X- (Sigma, Catalog # T9) 3

6 SAMPLE COLLECTION & STORAGE The sample collection and storage conditions listed below are intended as general guidelines. Sample stability has not been evaluated. Since the Human Angiogenesis Array detects relative expression levels of individual analytes, it is important to include appropriate control samples. Note: Sample amount may be empirically adjusted to attain optimal sensitivity with minimal background. Suggested starting ranges are - μl for cell culture supernates, -3 μg for cell and tissue lysates, and - μl for serum, plasma, and saliva samples. Cell Culture Supernates - Remove particulates by centrifugation. Assay immediately or aliquot and store samples at - C. Avoid repeated freeze-thaw cycles. Cell Lysates - Rinse cells with PBS, making sure to remove any remaining PBS before adding lysis buffer. Solubilize cells at x cells/ml in lysis buffer. Pipette up and down to resuspend and rock the lysates gently at - C for 3 minutes. Microcentrifuge at, x g for minutes, and transfer the supernate into a clean test tube. Quantitation of sample protein concentrations using a total protein assay is recommended. Assay immediately or aliquot and store at - C. Avoid repeated freeze-thaw cycles. Tissue Lysates - Excise tissue and homogenize in PBS with protease inhibitors. After homogenization, add Triton X- to a final concentration of %. Freeze samples at - C, thaw, and centrifuge at, x g for minutes to remove cellular debris. Quantitation of sample protein concentrations using a total protein assay is recommended. Assay immediately or aliquot and store samples at - C. Avoid repeated freeze-thaw cycles. Serum - Allow blood samples to clot for 3 minutes at room temperature before centrifuging for minutes at x g. Remove serum and assay immediately or aliquot and store samples at - C. Avoid repeated freeze-thaw cycles. Plasma - Collect plasma using EDTA or heparin as an anticoagulant. Centrifuge for minutes at x g within 3 minutes of collection. Assay immediately or aliquot and store samples at - C. Avoid repeated freeze-thaw cycles. Saliva - Collect saliva using a collection device such as a Salivette or equivalent. Assay immediately or aliquot and store samples at - C. Avoid repeated freeze-thaw cycles. Note: Saliva collector must not have any protein binding or filtering capabilities. For research use only. Not for use in diagnostic procedures.

7 REAGENT PREPARATION Bring all reagents to room temperature before use. Human Angiogenesis Array - Four nitrocellulose membranes each containing different capture antibodies printed in duplicate. Handle membranes only with gloved hands and flat-tipped tweezers. Detection Antibody Cocktail - One vial of lyophilized biotinylated antibodies. Before use, reconstitute the Detection Antibody Cocktail with μl of deionized or distilled water. X Wash Buffer - If crystals have formed in the concentrate, warm bottles to room temperature and mix gently until crystals have completely dissolved. Add ml of X Wash Buffer Concentrate to 9 ml of deionized or distilled water to prepare ml of X Wash Buffer. Chemi Reagent Mix - Chemi Reagent and should be mixed in equal volumes within minutes of use. Protect from light. ml of resultant mixture is required per membrane. OPTIONAL PRETREATMENT Some array targets may be complexed with binding proteins in human serum. A pretreatment step can dissociate the binding proteins and increase the signals seen on the array. See the Appendix for the affected analytes.. Prepare a solution of. N hydrochloric acid in deionized water.. Mix μl of serum with μl of acid solution. 3. Incubate for minutes on a rocking platform shaker. The sample is now ready for use in step of the Array Procedure.

8 ARRAY PROCEDURE Bring all reagents to room temperature before use. Keep samples on ice. To avoid contamination, wear gloves while performing the procedures.. Prepare all reagents and samples as directed in the previous sections.. Pipette. ml of Array Buffer into each well of the -Well Multi-dish to be used. Array Buffer serves as a block buffer. 3. Using flat-tip tweezers, remove each membrane to be used from between the protective sheets and place in a well of the -Well Multi-dish. The number on the membrane should be facing upward. Note: Upon contact with Array Buffer, the blue dye from the spots will disappear, but the capture antibodies are retained in their specific locations.. Incubate for one hour on a rocking platform shaker. Orient the tray so that each membrane rocks end to end in its well.. While the membranes are blocking, prepare samples by adding up to ml of each sample to. ml of Array Buffer in separate tubes. Adjust to a final volume of. ml with Array Buffer as necessary.. Add μl of reconstituted Detection Antibody Cocktail to each prepared sample. Mix and incubate at room temperature for one hour.. Aspirate Array Buffer from the wells of the -Well Multi-dish and add sample/antibody mixtures prepared in steps and. Place the lid on the -Well Multi-dish.. Incubate overnight at - C on a rocking platform shaker. Note: A shorter incubation time may be used if optimal sensitivity is not required. 9. Carefully remove each membrane and place into individual plastic containers with ml of X Wash Buffer. Rinse the -Well Multi-dish with deionized or distilled water and dry thoroughly.. Wash each membrane with X Wash Buffer for minutes on a rocking platform shaker. Repeat two times for a total of three washes.. Dilute the Streptavidin-HRP in Array Buffer using the dilution factor on the vial label. Pipette. ml of diluted Streptavidin-HRP into each well of the -Well Multi-dish.. Carefully remove each membrane from its wash container. Allow excess buffer to drain from the membrane. Return the membrane to the -Well Multi-dish containing the diluted Streptavidin-HRP. Cover the wells with the lid. 3. Incubate for 3 minutes at room temperature on a rocking platform shaker. For research use only. Not for use in diagnostic procedures.

9 ARRAY PROCEDURE CONTINUED. Wash each array as described in steps 9 and. Note: Complete the remaining steps without interruption.. Carefully remove each membrane from the wash container. Allow excess Wash Buffer to drain from the membrane by blotting the lower edge onto paper towels. Place each membrane on the bottom sheet of a plastic sheet protector with the identification number facing up.. Pipette ml of the prepared Chemi Reagent Mix evenly onto each membrane. Note: Using less than ml of Chemi Reagent Mix per membrane may result in incomplete membrane coverage.. Carefully cover with the top sheet of the plastic sheet protector. Gently smooth out any air bubbles and ensure Chemi Reagent Mix is spread evenly to all corners of each membrane. Incubate for minute at room temperature.. Position paper towels on the top and sides of the plastic sheet protector containing the membranes and carefully squeeze out excess Chemi Reagent Mix. 9. Remove the top plastic sheet protector and carefully lay an absorbent lab wipe on top of the membranes to blot off any remaining Chemi Reagent Mix.. Leaving membranes on the bottom plastic sheet protector, cover the membranes with plastic wrap taking care to gently smooth out any air bubbles. Wrap the excess plastic wrap around the back of the sheet protector so that the membranes and sheet protector are completely wrapped.. Place the membranes in an autoradiography film cassette with the identification numbers facing up. Note: Use an autoradiography cassette that is not used with radioactive isotope detection.. Expose membranes to X-ray film for - minutes. Multiple exposure times are recommended.

10 DATA ANALYSIS The positive signals seen on developed film can be quickly identified by placing the transparency overlay on the array image and aligning it with the pairs of reference spots in three corners of each array. The stamped identification number on the array should be placed on the left hand side. The location of controls and capture antibodies is listed in the Appendix. Note: Reference spots are included to align the transparency overlay template and to demonstrate that the array has been incubated with Streptavidin-HRP during the assay procedure. Pixel densities on developed X-ray film can be collected and analyzed using a transmissionmode scanner and image analysis software.. Create a template to analyze pixel density in each spot of the array.. Export signal values to a spreadsheet file for manipulation in a program such as Microsoft Excel. 3. Determine the average signal (pixel density) of the pair of duplicate spots representing each angiogenesis-related protein.. Subtract an averaged background signal from each spot. Use a signal from a clear area of the array or negative control spots as a background value.. Compare corresponding signals on different arrays to determine the relative change in angiogenesis-related proteins between samples. Human Angiogenesis Array Coordinates A B C D E F This image is not to scale. It is for coordinate reference only. Please use the transparency overlay for analyte identification. For research use only. Not for use in diagnostic procedures.

11 PROFILING ANGIOGENESIS-RELATED PROTEINS IN CELL CULTURE SUPERNATES The Human Angiogenesis Array detects multiple analytes in various tissue culture supernates. Cells were treated as indicated below. µl of cell culture supernate was run on each array. Data shown are from a minute exposure to X-ray film. A THP-+IFN-γ+LPS EGF Endostatin GM-CSF IGFBP- IGFBP-3 IL-β IL- MCP- MIP-α Pentraxin 3 PDGF-AA Serpin E TIMP- Thrombospondin- upa Figure A: THP- human acute monocytic leukemia cells were treated with μg/ml rhifn-γ (R&D Systems, Catalog # -IF) for hours followed by the addition of μg/ml of lipopolysaccharide (LPS) for hours. B HUVEC + LPS EGF Endostatin GM-CSF IGFBP- IGFBP-3 IL-β IL- MCP- MIP-α Pentraxin 3 PDGF-AA Serpin E TIMP- Thrombospondin- upa 9 3 Figure B: HUVEC human umbilical vein endothelial cells were treated with μg/ml of LPS for hours. 9

12 PROFILING ANGIOGENESIS-RELATED PROTEINS IN TUMOR TISSUE LYSATES The Human Angiogenesis Array detects multiple analytes in various tumor tissue lysates. µg of lysate was run on each array. Data shown are from a minute exposure to X-ray film. A Prostate Cancer Angiogenin Coagulation Factor III DPPIV Endostatin FGF acidic IGFBP- IGFBP- IL- LAP (TGF-β) MMP- Pentraxin 3 PD-ECGF PDGF-AA PF Serpin B Serpin E Serpin F TIMP- Thrombospondin- upa VEGF B Ovarian Cancer Angiogenin Coagulation Factor III DPPIV Endostatin FGF acidic IGFBP- IGFBP- IL- LAP (TGF-β) MMP- Pentraxin 3 PD-ECGF PDGF-AA PF Serpin B Serpin E Serpin F TIMP- Thrombospondin- upa VEGF C Breast Cancer Angiogenin Coagulation Factor III DPPIV Endostatin FGF acidic IGFBP- IGFBP- IL- LAP (TGF-β) MMP- Pentraxin 3 PD-ECGF PDGF-AA PF Serpin B Serpin E Serpin F TIMP- Thrombospondin- upa VEGF 9 For research use only. Not for use in diagnostic procedures.

13 PROFILING ANGIOGENESIS-RELATED PROTEINS IN SERUM, PLASMA, AND SALIVA The Human Angiogenesis Array detects multiple analytes in serum, plasma, and saliva. All samples were obtained from the same donor. µl of sample was run on each array. Data shown are from a minute exposure to X-ray film. A Serum Angiogenin DPPIV EGF Endostatin IGFBP- IGFBP- IGFBP-3 IL- Leptin MMP- NRG-β Pentraxin 3 PDGF-AA PDGF-BB PF Serpin B Serpin E TIMP- Thrombspondin- VEGF B Plasma 9 9 Sodium Heparin EDTA Sodium Heparin Plasma EDTA Plasma 3 9 Angiogenin DPPIV EGF Endostatin IGFBP- IGFBP- IGFBP-3 IL- Leptin MMP- NRG-β Pentraxin 3 PDGF-AA PDGF-BB PF Serpin B Serpin E TIMP- Thrombspondin- VEGF 9 C Saliva Angiogenin DPPIV EGF Endostatin IGFBP- IGFBP- IGFBP-3 IL- Leptin MMP- NRG-b Pentraxin 3 PDGF-AA PDGF-BB PF Serpin B Serpin E TIMP- Thrombspondin- VEGF 3

14 EFFECTS OF HYPOXIA ON SOLUBLE FACTORS The Human Angiogenesis Array shows the effects of hypoxia on soluble factors. HepG human hepatocellular carcinoma cells were untreated or treated as below. µl of cell culture supernate was run on each array. Data shown are from a minute exposure to X-ray film. A B C Untreated CoCl Treated Deferoxamine Treated 3 3 CXCL DPPIV HepG Untreated vs. Hypoxia Untreated CoCl Treated Deferoxamine Treated 3 GDNF GM-CSF HB-EGF Serpin E Serpin F A. Untreated B. Treated with 3 μm CoCl for hours. C. Treated with 3 μm Deferoxamine for hours. For research use only. Not for use in diagnostic procedures.

15 APPENDIX Refer to the table below for the Human Angiogenesis Array coordinates. Coordinate Target/Control Gene ID Alternate Nomenclature Effects of Pretreatment A, A Reference Spots N/A A, A Activin A 3 A, A ADAMTS- 9 A9, A Angiogenin 3 ANG A, A Angiopoietin- Ang- _ A3, A Angiopoietin- Ang- A, A Angiostatin/Plasminogen 3 A, A Amphiregulin 3 AR A9, A Artemin 9 A3, A Reference Spots N/A B, B Coagulation Factor III TF B3, B CXCL 9 B, B DPPIV 3 CD B, B EGF 9 B9, B EG-VEGF 3 PK B, B Endoglin CD B3, B Endostatin/Collagen XVIII B, B Endothelin- 9 ET- + B, B FGF acidic FGF- B9, B FGF basic 3 FGF- B, B FGF- 9 B3, B FGF- KGF C, C GDNF C3, C GM-CSF 3 C, C HB-EGF 39 C, C HGF 3 C9, C IGFBP- 3 C, C IGFBP- 3 C3, C IGFBP-3 3 C, C IL-β 33 IL-F C, C IL- 3 CXCL C9, C LAP (TGF-β) + C, C Leptin 39 C3, C MCP- 3 CCL continued on next page

16 APPENDIX CONTINUED Coordinate Target/Control Gene ID Alternate Nomenclature Effects of Pretreatment D, D MIP-α 3 CCL3 D3, D MMP- 3 + D, D 3 D, D NRG-β 3 HRG-β D9, D Pentraxin 3 (PTX3) TSG- _ D, D PD-ECGF 9 D3, D PDGF-AA D, D PDGF-AB/PDGF-BB D, D Persephin 3 D9, D Platelet Factor (PF) 9 CXCL D, D PlGF D3, D Prolactin E, E Serpin B Maspin + E3, E Serpin E PAI- E, E Serpin F PEDF E, E TIMP- E9, E TIMP- 9 E, E Thrombospondin- TSP- E3, E Thrombospondin- TSP- E, E upa 3 E, E Vasohibin E9, E VEGF E, E VEGF-C F, F Reference Spots N/A F3, F Negative Control N/A Control (-) All trademarks and registered trademarks are property of their respective owners. R&D Systems, Inc... / For research use only. Not for use in diagnostic procedures.